FOI release

Singulair 10 mg film-coated tablets and Eliquis 2.5 mg and 5 mg film-coated tablets

Case reference FOI2026/00121

Received 5 February 2026

Published 23 March 2026

Request

I am writing a Freedom of Information request in order to request the following for 2 products, Singulair 10 mg film-coated tablets (PL 00025/0358) and Eliquis 2.5 mg and 5 mg film-coated tablets (PLGB 54213/0001-2): * Please can you confirm the legal basis and route of authorisation? * Please can you confirm the licencing history of these products? * Please can you provide the public assessment report?

Response

See attached

Documents

• FOI2026_00121 (redacted).pdf (609.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.